Literature DB >> 10459586

The role of Pseudomonas aeruginosa elastase as a potent inflammatory factor in a rat air pouch inflammation model.

Y Kon1, H Tsukada, T Hasegawa, K Igarashi, K Wada, E Suzuki, M Arakawa, F Gejyo.   

Abstract

Pseudomonas aeruginosa, an opportunistic pathogen, can cause life threatening infections in patients compromised by underlying respiratory disease like bronchiectasis, cystic fibrosis and diffuse panbronchiolitis. Most strains of P. aeruginosa produce some kind of protease with broad substrate specificities during the infectious state in the host. P. aeruginosa elastase, one of the strongest exotoxins, has a tissue-damaging proteolytic activity and is capable of degrading such plasma proteins as immunoglobulins, complement factor and cytokines. The present study focused on the effect of P. aeruginosa elastase and was designed to evaluate the neutrophil accumulation at the inflammation site mediated by P. aeruginosa elastase in the inflammatory response in the host. An air pouch model in rats, considered as a useful model of inflammation, was used to analyze the number of leukocytes, the volume of exudate and the concentration of interleukin-8 after the injection of P. aeruginosa elastase into the pouch cavity. The number of neutrophils and the volume of exudate in the pouch cavity increased significantly at 4 h, peaked at 8 h in a dose-dependent manner and then decreased at 24 h. The concentration of interleukin-8 in pouch fluid peaked 4 h earlier than the peak of the neutrophil number. The enzymatic activity of P. aeruginosa elastase seemed to reinforce the inflammation process. The influence of lipopolysaccharide contamination was negligible. Although these observations were made in the subcutaneous cavity, they indicate that P. aeruginosa elastase plays a role as an immunoprovocative factor in the inflammatory response in cases of infection with P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10459586     DOI: 10.1111/j.1574-695X.1999.tb01356.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  13 in total

1.  Mechanism of fibroblast inflammatory responses to Pseudomonas aeruginosa elastase.

Authors:  Ali O Azghani; Kourtney Neal; Steven Idell; Rodolfo Amaro; Jason W Baker; Abdelwahab Omri; Usha R Pendurthi
Journal:  Microbiology (Reading)       Date:  2014-01-02       Impact factor: 2.777

Review 2.  The detrimental impact of extracellular bacterial proteases on wound healing.

Authors:  Sharon Lindsay; Angela Oates; Katie Bourdillon
Journal:  Int Wound J       Date:  2017-07-25       Impact factor: 3.315

3.  Novel inhibitors of the Pseudomonas aeruginosa virulence factor LasB: a potential therapeutic approach for the attenuation of virulence mechanisms in pseudomonal infection.

Authors:  George R A Cathcart; Derek Quinn; Brett Greer; Pat Harriott; John F Lynas; Brendan F Gilmore; Brian Walker
Journal:  Antimicrob Agents Chemother       Date:  2011-03-28       Impact factor: 5.191

4.  Anti-inflammatory activity of hyperimmune plasma in a lipopolysaccharide-mediated rat air pouch model of inflammation.

Authors:  Bryan E Essien; Michael Kotiw
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

5.  Protease-activated receptor-2 (PAR-2) is a weak enhancer of mucin secretion by human bronchial epithelial cells in vitro.

Authors:  Ko-Wei Lin; Joungjoa Park; Anne L Crews; Yuehua Li; Kenneth B Adler
Journal:  Int J Biochem Cell Biol       Date:  2007-11-09       Impact factor: 5.085

6.  Evolution of Pseudomonas aeruginosa virulence as a result of phage predation.

Authors:  Zeinab Hosseinidoust; Theo G M van de Ven; Nathalie Tufenkji
Journal:  Appl Environ Microbiol       Date:  2013-07-26       Impact factor: 4.792

7.  PAR-2-activated secretion by airway gland serous cells: role for CFTR and inhibition by Pseudomonas aeruginosa.

Authors:  Derek B McMahon; Ryan M Carey; Michael A Kohanski; Nithin D Adappa; James N Palmer; Robert J Lee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-03-03       Impact factor: 5.464

8.  Effective antiprotease-antibiotic treatment of experimental anthrax.

Authors:  Serguei G Popov; Taissia G Popova; Svetlana Hopkins; Raymond S Weinstein; Rebecca MacAfee; Karl J Fryxell; Vikas Chandhoke; Charles Bailey; Ken Alibek
Journal:  BMC Infect Dis       Date:  2005-04-08       Impact factor: 3.090

9.  Screening of Lactobacillus spp. for the prevention of Pseudomonas aeruginosa pulmonary infections.

Authors:  Youenn Alexandre; Rozenn Le Berre; Georges Barbier; Gwenaelle Le Blay
Journal:  BMC Microbiol       Date:  2014-04-27       Impact factor: 3.605

10.  A Comparative Analysis of Synthetic Quorum Sensing Modulators in Pseudomonas aeruginosa: New Insights into Mechanism, Active Efflux Susceptibility, Phenotypic Response, and Next-Generation Ligand Design.

Authors:  Joseph D Moore; Francis M Rossi; Michael A Welsh; Kayleigh E Nyffeler; Helen E Blackwell
Journal:  J Am Chem Soc       Date:  2015-11-11       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.